Volpara Health Technologies Ltd (ASX: VHT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Volpara Health Technologies Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $289.99 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 254.83 million
Earnings per share -0.036
Dividend per share N/A
Year To Date Return 3.17%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Volpara Health Technologies Ltd (ASX: VHT)
    Latest News

    Three children wearing silver thinking hats with light bulbs attached to them.
    Growth Shares

    Down over 30% in 2022: 2 compelling ASX tech shares

    These two ASX tech shares have fallen heavily in 2022.

    Read more »

    Growth Shares

    2 ASX shares every growth investor needs to know about

    Growth investors need to know about these 2 ASX shares.

    Read more »

    Man presses green buy button and red sell button on a graph.
    Broker Notes

    Broker names 3 speculative ASX shares to buy

    Here are three speculative shares rated as buys...

    Read more »

    disembodied hands in pink surgical gloves making heart shape
    Technology Shares

    2 top ASX tech shares for February 2022

    February could be the month for these ASX tech shares.

    Read more »

    A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
    Small Cap Shares

    3 exciting small cap ASX shares to watch

    Here are three small caps to watch closely...

    Read more »

    growth charts with small cap written on a sticky note
    Small Cap Shares

    2 small cap ASX shares with a lot of potential: experts

    City Chic is one small cap ASX share that may have tons of potential.

    Read more »

    A young man working from home sits at his home office desk holding a cup of tea and looking out the window
    Small Cap Shares

    2 exciting small cap ASX shares named as buys

    Check out these small cap shares...

    Read more »

    Green keyboard button saying buy stock
    Technology Shares

    Are these 2 ASX tech shares good buys in January?

    Xero is one of the ASX tech shares that could be a good buy in January.

    Read more »

    A group of executives sit in front of computer screens in a darkened room while a colleague stands giving a presentation with a share price graphic lit up on the wall
    Small Cap Shares

    3 exciting small cap ASX shares rated as buys

    Check out these highly rated small cap ASX shares...

    Read more »

    four excited doctors with their hands in the air
    Healthcare Shares

    Experts rate these 2 ASX healthcare shares as buys in 2022

    Volpara is one of the ASX healthcare shares that experts like for 2022.

    Read more »

    Mother and young children at doctors
    Growth Shares

    2 fast growth ASX shares that could be buys in December 2021

    Volpara is one of the ASX growth shares that could be compelling in December 2021.

    Read more »

    A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital
    Earnings Results

    Best-ever result: Volpara Health (ASX:VHT) share price jumps on half-year update

    It's been a good start to the trading day for the medical technology company

    Read more »

    Frequently Asked Questions

    No, the ASX healthcare share has not yet paid any dividends.

    Volpara listed on 27 April 2016.

    VHT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Volpara Health Technologies Ltd

    Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.

    Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.

    VHT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    24 Apr 2024 $1.14 $0.00 0.00% 1,385,421 $1.14 $1.15 $1.14
    23 Apr 2024 $1.14 $0.00 0.00% 70,916 $1.14 $1.15 $1.14
    22 Apr 2024 $1.14 $0.00 0.00% 71,273 $1.14 $1.15 $1.14
    19 Apr 2024 $1.14 $0.00 0.00% 935,592 $1.14 $1.14 $1.14
    18 Apr 2024 $1.14 $0.00 0.00% 1,057,317 $1.15 $1.15 $1.14
    17 Apr 2024 $1.14 $0.00 0.00% 400,464 $1.14 $1.14 $1.14
    16 Apr 2024 $1.14 $0.00 0.00% 188,376 $1.14 $1.14 $1.14
    15 Apr 2024 $1.14 $0.00 0.00% 176,419 $1.14 $1.14 $1.14
    12 Apr 2024 $1.14 $0.00 0.00% 689,013 $1.14 $1.14 $1.14
    11 Apr 2024 $1.14 $0.00 0.00% 299,719 $1.14 $1.14 $1.14
    10 Apr 2024 $1.14 $0.00 0.00% 167,783 $1.14 $1.14 $1.14
    09 Apr 2024 $1.14 $0.00 0.00% 719,436 $1.14 $1.14 $1.14
    08 Apr 2024 $1.14 $0.00 0.00% 333,112 $1.14 $1.14 $1.13
    05 Apr 2024 $1.14 $0.01 0.88% 510,800 $1.14 $1.14 $1.14
    04 Apr 2024 $1.13 $-0.01 -0.88% 44,939 $1.14 $1.14 $1.13
    03 Apr 2024 $1.14 $0.01 0.88% 143,349 $1.13 $1.14 $1.13
    02 Apr 2024 $1.13 $-0.01 -0.88% 168,164 $1.13 $1.14 $1.13
    28 Mar 2024 $1.14 $0.00 0.00% 539,358 $1.13 $1.14 $1.13
    27 Mar 2024 $1.14 $0.00 0.00% 127,606 $1.13 $1.14 $1.13

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    17 Aug 2023 Mark Bouw Issued 450,000 $585,000
    Issue of options.
    02 Jun 2023 Teri Thomas Sell 3,577 $2,546
    On-market trade.
    01 Jun 2023 Teri Thomas Exercise 75,280 $57,213
    Conversion of securities. 150,561 RSUs, As per announcement on 02-06-2023
    01 Jun 2023 Teri Thomas Buy 75,280 $57,213
    Conversion of securities. As per announcement on 02-06-2023

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Roger Allen Non-Executive Director Jun 2010
    Roger was Volpara s first major investor, joined the Board
    prior to FDA approval in June 2010, and was Chair from
    October 2015 to March 2019.
    Roger is a well-known entrepreneur, venture capitalist (VC),
    and social impact investor and philanthropist whose global
    career has spanned over 50 years. He helped pioneer the
    Australian technology industry through the Computer
    Power Group, one of the first Australian-founded tech
    companies to scale globally and subsequently IPO in 1987,
    turning over approx. $1B in today s currency. Following
    the companys acquisition in 1995, he cofounded Allen &
    Buckeridge Pty Ltd, one of the first early-stage VC firms.
    Mr John Dimitrious Pavlidis Non-Executive Director Feb 2015
    John Pavlidis joined the VHT board in February
    2015 and has more than 30 years of experience
    as a senior healthcare executive, CEO, or
    company director in the areas of womens health,
    diagnostic imaging, image analysis and artificial
    intelligence, and cardiovascular therapies.
    Mr Paul Reid Non-Executive DirectorNon-Executive Chairman Mar 2018
    Paul joined the Board in March 2018 and brings extensive
    commercial experience gained across a range of
    technology/Software as a Service businesses.
    He was the founding CEO and Chairman of Figured
    Limited, a fintech SaaS company that provides
    management accounting software to farmers in the
    United States, the United Kingdom ,
    Australia, and New Zealand . Figured was the
    NZ Hi-Tech Startup Company of the Year in 2016 and
    has grown at an incredible pace, funded by private,
    corporate and venture capital (VC) investors.
    Ms Karin Lindgren Non-Executive Director Jan 2020
    Karin joined the Board in 2020. She brings over 35 years
    experience in health information technology as a senior
    technology executive and law firm partner. As one of
    the earliest healthcare technology lawyers in the USA,
    Karin has an in-depth knowledge of data governance,
    data privacy, SaaS, and US healthcare, and has extensive
    professional networks across the IT landscape
    Ms Ann Custin Non-Executive Director Sep 2021
    network of industry contacts from an extensive
    career in healthcare across Europe, the Americas,
    and Asia. Her most recent executive role was with
    Siemens Healthineers, where she served as both CFO
    and board director of Siemens Medical Solutions.
    Prior to this role, Ann served as Chief Operating
    and Financial Officer of Scientx and President &
    CEO of USA Draeger Medical Systems, Inc.
    Ms Teri Thomas Chief Executive OfficerManaging Director Apr 2022
    Teri joined the Board in October 2022. She has a
    long history of executive management in healthcare
    IT ranging from strategy and operations to running
    global sales and marketing teams. This includes a
    20-year career at Epic, a global leader in electronic
    health record (EHR) systems and other software
    solutions used by hospitals and healthcare
    organisations in the United States and internationally
    Mr Mark Bouw Non-Executive Director Jan 2023
    Mr Bouw is a experienced senior healthcare CEO .He is a visiting consultant at Stanford University Graduate Business School Seed Program in the United States and is a visiting mentor for Stanfords Ignite program.
    Mr Craig Hadfield Chief Financial OfficerJoint Company Secretary Mar 2017
    -
    Mr Fred Struve General CounselJoint Company Secretary Oct 2022
    -
    Craig Hadfield Chief Financial OfficerJoint Company Secretary
    -
    Fred Struve General CounselJoint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    No Top 20 27,534,688 10.84%
    Patagorang Pty Ltd 18,467,848 7.27%
    Ralph Highnam And Kyc Trustees 106 Limited <Highnam Share A/C> 16,213,561 6.38%
    Citicorp Nominees Pty Limited 11,830,450 4.66%
    HSBC Custody Nominees (Australia) Limited 8,187,911 3.22%
    Custodial Services Limited <Beneficiaries Holding A/C> 8,154,911 3.21%
    Bnp Paribas Noms (Nz) Ltd <Drp> 7,061,556 2.78%
    Prof Sir Michael Brady 6,619,075 2.61%
    Mr Marcus Sarner 5,980,404 2.35%
    National Nominees Limited 4,728,818 1.86%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient 4,420,193 1.74%
    Sir Martin Francis Wood 3,004,655 1.18%
    Lady Kathleen Audrey Wood 3,004,654 1.18%
    BNP Paribas Noms Pty Ltd <Drp> 2,527,511 0.99%
    Prof Martin Yaffe 1,966,483 0.77%
    Mr John Anthony Dell 1,928,864 0.76%
    BNP Paribas Nominees Pty Ltd HUB24 Custodial Serv Limited 1,917,409 0.75%
    Prof Nico Karssemeijer 1,806,806 0.71%
    Melbourne Securities Corporation Limited <Horizon 3 Biotech Fund A/C> 1,519,964 0.60%
    RX HOUSE TRUST PTY LTD 880,758 0.35%

    Profile

    since

    Note